Site FMPMC
     Page précédentePage suivanteSommaireVersion imprimable
   
 

Résistances aux β-lactamines

Table des matières

1 - Aeromonas hydrophila

2 - Acinetobacter

3 - Bacteroides fragilis

4 - Citrobacter diversus

5 - Citrobacter freundii

6 - Enterobacter

7 - Escherichia coli

8 - Klebsiella oxytoca

9 - Klebsiella pneumoniae

10 - Morganella morganii

11 - Proteus mirabilis

12 - Proteus vulgaris

13 - Providencia

14 - Pseudomonas

15 - Serratia marcescens

16 - Stenotrophomonas maltophilia (Xanthomonas)

17 - Salmonella

Références


Tous droits de reproduction réservés aux auteurs


traduction HTML V2.8
V. Morice


Références

 

 

[1]  Arlet G. Rouveau M. Casin I. Bouvet PJ. Lagrange PH. Philippon A.
Molecular epidemiology of klebsiella pneumoniae strains that produce shv-4 beta-lactamase and which were isolated in 14 french hospitals.
Journal of Clinical Microbiology., pages 2553-8, 1994 Oct.
[2]  Arlet G. Rouveau M. Philippon A.
Substitution of alanine for aspartate at position 179 in the shv-6 extended-spectrum beta-lactamase.
FEMS Microbiology Letters., pages 163-7, 1997 Jul 1.
[3]  Barnaud G. Arlet G. Danglot C. Philippon A.
Cloning and sequencing of the gene encoding the ampc beta-lactamase of morganella morganii.
FEMS Microbiology Letters., pages 15-20, 1997 Mar 1.
[4]  Fournier B. Arlet G. Lagrange PH. Philippon A.
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase.
FEMS Microbiology Letters., pages 31-6, 1994 Feb 1.
[5]  Fournier B. Lagrange PH. Philippon A.
beta-lactamase gene promoters of 71 clinical strains of klebsiella oxytoca.
Antimicrobial Agents and Chemotherapy., pages 40-3, 1996 Feb.
Abstract.
[6]  Fournier B. Lu CY. Lagrange PH. Krishnamoorthy R. Philippon A.
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in klebsiella oxytoca.
Antimicrobial Agents and Chemotherapy., pages 1365-8, 1995 Jun.
[7]  Fournier B. Roy PH. Lagrange PH. Philippon A.
Chromosomal beta-lactamase genes of klebsiella oxytoca are divided into two main groups, blaoxy-1 and blaoxy-2.
Antimicrobial Agents and Chemotherapy., pages 454-9, 1996 Feb.
[8]  Handfield J. Gagnon L. Dargis M. Huletsky A.
Sequence of the pona gene and characterization of the penicillin-binding protein 1a of pseudomonas aeruginosa pao1.
Gene., pages 49-56, 1997 Oct 15.
[9]  Marchese A. Arlet G. Schito GC. Lagrange PH. Philippon A.
Detection of shv-5 extended-spectrum beta-lactamase in klebsiella pneumoniae strains isolated in italy.
European Journal of Clinical Microbiology and Infectious Diseases., pages 245-8, 1996 Mar.
[10]  Neuwirth C. Siebor E. Duez JM. Pechinot A. Kazmierczak A.
Imipenem resistance in clinical isolates of proteus mirabilis associated with alterations in penicillin-binding proteins.
Journal of Antimicrobial Chemotherapy., pages 335-42, 1995 Aug.
Abstract.
[11]  Neuwirth C. Siebor E. Lopez J. Pechinot A. Kazmierczak A.
Outbreak of tem-24-producing enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.
Journal of Clinical Microbiology., pages 76-9, 1996 Jan.
[12]  Tzouvelekis LS. Tzelepi E. Mentis AF. Tsakris A.
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from klebsiella pneumoniae.
Journal of Antimicrobial Chemotherapy., pages 645-54, 1993 May.
[13]  Tzouvelekis LS. Tzelepi E. Kaufmann ME. Mentis AF.
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of enterobacter aerogenes.
Journal of Medical Microbiology., pages 403-7, 1994 Jun.
[14]  Ramadan MA. Tawfik AF. Shibl AM.
Effect of beta-lactamase expression on susceptibility of local isolates of enterobacter cloacae, serratia marcescens and pseudomonas aeruginosa to beta-lactam antibiotics.
Chemotherapy., pages 193-9, 1995 May-Jun.
[15]  Alksne LE. Rasmussen BA.
Expression of the asba1, oxa-12, and asbm1 beta-lactamases in aeromonas jandaei aer 14 is coordinated by a two-component regulon.
Journal of Bacteriology, pages 2006-13, 1997 Mar.
[16]  Elksne LE. Rasmussen BA.
Dsb-insensitive expression of ccra, a metallo-beta-lactamase from bacteroides fragilis, in escherichia coli after amino acid substitution at two cysteine residues within ccra.
Journal of Bacteriology., pages 4306-9, 1996 Jul.
[17]  Bermudes H. Arpin C. Jude F. Elharrif Z. Bebear C. Quentin C.
Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a french hospital.
European Journal of Clinical Microbiology and Infectious Diseases., pages 523-529, 1997 Jul.
Klebsiella-pneumoniae. Resistance. Dna.
[18]  El Harrif-Heraud Z. Arpin C. Benliman S. Quentin C.
Molecular epidemiology of a nosocomial outbreak due to shv-4-producing strains of citrobacter diversus.
Journal of Clinical Microbiology., pages 2561-7, 1997 Oct.
[19]  El Harrif-Heraud Z. Arpin C. Quentin C.
Characterization of blatem-3 and blashv-4 beta-lactamase-encoding genes in citrobacter diversus.
Antimicrobial Agents and Chemotherapy., pages 2589-90, 1997 Nov.
[letter].
[20]  Khushi T. Payne DJ. Fosberry A. Reading C.
Production of metal dependent beta-lactamases by clinical strains of bacteroides fragilis isolated before 1987.
Journal of Antimicrobial Chemotherapy., pages 345-50, 1996 Feb.
[21]  Vila J. Navia M. Ruiz J. Casals C.
cloning and nucleotide sequence analysis of a gene encoding an oxa-derived beta-lactamase in acinetobacter baumannii.
Antimicrobial Agents and Chemotherapy., 41(12):2757-9, 1997 Dec.
[22]  Sayeed S. Saunders JR. Edwards C. Corkill JE. Hart CA.
Expression of aeromonas caviae bla genes in escherichia coli.
Journal of Antimicrobial Chemotherapy., pages 435-41, 1996 Sep.
[23]  Coudron PE. Moland ES. Sanders CC.
Occurrence and detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae at a veterans medical center.
Journal of Clinical Microbiology., pages 2593-2597, 1997 Oct.
[24]  Edwards R. Greenwood D.
Mechanisms responsible for reduced susceptibility to imipenem in bacteroides fragilis.
Journal of Antimicrobial Chemotherapy., pages 941-51, 1996 dec.
[25]  Edwards R. Greenwood D.
Distinctive outer membrane protein and lipopolysaccharide composition of bacteroides fragilis strains that produce metallo- beta-lactamase.
Anaerobe., pages 233-236, 1997 Aug.
Outer membrane profile. Bacteroides fragilis. Metallo-beta- lactamases.
[26]  Edwards R. Hashmi PS. Greenwood D.
The effect of zinc ions on the activity of metallo-beta- lactamases of bacteroides fragilis.
Journal of Medical Microbiology., pages 807-9, 1997 Sep.
[27]  de Champs C. Sirot D. Chanal C. Poupart MC. Dumas MP. Sirot J.
Concomitant dissemination of three extended-spectrum beta-lactamases among different enterobacteriaceae isolated in a french hospital.
Journal of Antimicrobial Chemotherapy., pages 441-57, 1991 Apr.
[28]  Toney JH. Wu JK. Overbye KM. Thompson CM. Pompliano DL.
High-yield expression, purification, and characterization of active, soluble bacteroides fragilis metallo-beta-lactamase, ccra.
Protein Expression and Purification., pages 355-62, 1997 Apr.
[29]  Danel F. Hall LM. Gur D. Akalin HE. Livermore DM.
Transferable production of per-1 beta-lactamase in pseudomonas aeruginosa.
Journal of Antimicrobial Chemotherapy., pages 281-94, 1995 Feb.
[30]  Danel F. Hall LM. Gur D. Livermore DM.
Oxa-14, another extended-spectrum variant of oxa-10 (pse-2) beta-lactamase from pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 1881-4, 1995 Aug.
[31]  Danel F. Hall LM. Gur D. Livermore DM.
Oxa-15, an extended-spectrum variant of oxa-2 beta-lactamase, isolated from a pseudomonas aeruginosa strain.
Antimicrobial Agents and Chemotherapy., pages 785-90, 1997 Apr.
[32]  Gheorghiu R. Yuan MF. Hall LMC. Livermore DM.
Bases of variation in resistance to beta-lactams in klebsiella oxytoca isolates hyperproducing k1 beta-lactamase.
Journal of Antimicrobial Chemotherapy., pages 533-541, 1997 Oct.
[33]  Jenks PJ. Hu YM. Danel F. Mehtar S. Livermore DM.
Plasmid-mediated production of class i (ampc) beta-lactamase by two klebsiella pneumoniae isolates from the uk.
Journal of Antimicrobial Chemotherapy., pages 235-6, 1995 Jan.
[letter].
[34]  Livermore DM.
Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 2046-8, 1992 Sep.
[35]  Luzzaro F. Pagani L. Porta F. Romero E.
Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of serratia marcescens.
Journal of Chemotherapy., pages 175-8, 1995 Jun.
[36]  Mugnier P. Podglajen I. Goldstein FW. Collatz E.
Carbapenems as inhibitors of oxa-13, a novel, integron-encoded beta-lactamase in pseudomonas aeruginosa.
Microbiology., pages 1021-1031, 1998 Apr.
[37]  Pagani L. Luzzaro F. Ronza P. Rossi A. Micheletti P. Porta F. Romero E.
Outbreak of extended-spectrum beta-lactamase producing serratia marcescens in an intensive care unit.
FEMS Immunology and Medical Microbiology., pages 39-46, 1994 Nov.
[38]  Podglajen I. Breuil J. Casin I. Collatz E.
Genotypic identification of two groups within the species bacteroides fragilis by ribotyping and by analysis of pcr-generated fragment patterns and insertion sequence content.
Journal of Bacteriology., pages 5270-5, 1995 Sep.
[39]  Ruimy R. Podglajen I. Breuil J. Christen R. Collatz E.
A recent fixation of cfia genes in a monophyletic cluster of bacteroides fragilis is correlated with the presence of multiple insertion elements.
Journal of Bacteriology., pages 1914-8, 1996 Apr.
[40]  Korfmann G. Sanders CC. Moland ES.
Altered phenotypes associated with ampd mutations in enterobacter cloacae.
Antimicrobial Agents and Chemotherapy., pages 358-64, 1991 Feb.
[41]  Gonzalez Leiza M. Perez-Diaz JC. Ayala J. Casellas JM. Martinez-Beltran J. Bush K. Baquero F.
Gene sequence and biochemical characterization of fox-1 from klebsiella pneumoniae, a new ampc-type plasmid-mediated beta-lactamase with two molecular variants.
Antimicrobial Agents and Chemotherapy., pages 2150-7, 1994 Sep.
[42]  Peixe LV. Sousa JC. Perez-Diaz JC. Baquero F.
A bla(tem-1b)-derived tem-6 beta-lactamase: a case of convergent evolution.
Antimicrobial Agents and Chemotherapy., page 1206, 1997 May.
[letter].
[43]  Vurma-Rapp U. Kayser FH. Hadorn K. Wiederkehr F.
Mechanism of imipenem resistance acquired by three pseudomonas aeruginosa strains during imipenem therapy.
European Journal of Clinical Microbiology and Infectious Diseases., 1991.
[44]  Rasheed JK. Jay C. Metchock B. Berkowitz F. Weigel L. Crellin J. Steward C. Hill B. Medeiros AA. Tenover FC.
Evolution of extended-spectrum beta-lactam resistance (shv-8) in a strain of escherichia coli during multiple episodes of bacteremia.
Antimicrobial Agents and Chemotherapy., pages 647-53, 1997 Mar.
[45]  Hejazi A. Falkiner FR.
Serratia marcescens [review].
Journal of Medical Microbiology., pages 903-912, 1997 Nov.
[46]  Belaaouaj A. Lapoumeroulie C. Canica MM. Vedel G. Nevot P. Krishnamoorthy R. Paul G.
Nucleotide sequences of the genes coding for the tem-like beta-lactamases irt-1 and irt-2 (formerly called tri-1 and tri-2).
FEMS Microbiology Letters., pages 75-80, 1994 Jul 1.
[47]  Canica MM. Barthelemy M. Gilly L. Labia R. Krishnamoorthy R. Paul G.
Properties of irt-14 (tem-45), a newly characterized mutant of tem-type beta-lactamases.
Antimicrobial Agents and Chemotherapy., pages 374-8, 1997 Feb.
[48]  Felici A. Amicosante G.
Kinetic analysis of extension of substrate specificity with xanthomonas maltophilia, aeromonas hydrophila, and bacillus cereus metallo-beta-lactamases.
Antimicrobial Agents and Chemotherapy., pages 192-9, 1995 Jan.
[49]  Perilli M. Felici A. Franceschini N. De Santis A. Pagani L. Luzzaro F. Oratore A. Rossolini GM. Knox JR. Amicosante G.
Characterization of a new tem-derived beta-lactamase produced in a serratia marcescens strain.
Antimicrobial Agents and Chemotherapy., pages 2374-82, 1997 Nov.
[50]  Perilli M. Felici A. Oratore A. Cornaglia G. Bonfiglio G. Rossolini GM. Amicosante G.
Characterization of the chromosomal cephalosporinases produced by acinetobacter lwoffii and acinetobacter baumannii clinical isolates.
Antimicrobial Agents and Chemotherapy, 40(3):715-9, 1996 Mar.
[51]  Rossolini GM. Walsh T. Amicosante G.
The aeromonas metallo-beta-lactamases: genetics, enzymology, and contribution to drug resistance. [review] [34 refs].
Microbial Drug Resistance., pages 245-52, 1996 Summer.
[52]  Huovinen P. Jacoby GA.
Sequence of the pse-1 beta-lactamase gene.
Antimicrobial Agents and Chemotherapy., pages 2428-30, 1991 Nov.
[53]  Rice LB. Marshall SH. Carias LL. Sutton L. Jacoby GA.
Sequences of mgh-1, you-1, and you-2 extended-spectrum beta-lactamase genes.
Antimicrobial Agents and Chemotherapy., pages 2760-1, 1993 Dec.
[54]  Ishii Y. Ohno A. Taguchi H. Imajo S. Ishiguro M. Matsuzawa H.
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class a beta-lactamase toho-1 isolated from escherichia coli.
Antimicrobial Agents and Chemotherapy., pages 2269-75, 1995 Oct.
[55]  Raimondi A. Traverso A. Nikaido H.
Imipenem- and meropenem-resistant mutants of enterobacter cloacae and proteus rettgeri lack porins.
Antimicrobial Agents and Chemotherapy., pages 1174-80, 1991 Jun.
[56]  Hall LM. Livermore DM. Gur D. Akova M. Akalin HE.
Oxa-11, an extended-spectrum variant of oxa-10 (pse-2) beta- lactamase from pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 1637-44, 1993 Aug.
[57]  Stapleton P. Shannon K. Phillips I.
Dna sequence differences of ampd mutants of citrobacter freundii.
Antimicrobial Agents and Chemotherapy., pages 2494-8, 1995 Nov.
[58]  Stapleton P. Shannon K. Phillips I.
The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from citrobacter freundii.
Journal of Antimicrobial Chemotherapy., pages 483-96, 1995 Sep.
[59]  Bret L. Chanal C. Sirot D. Labia R. Sirot J.
Characterization of an inhibitor-resistant enzyme irt-2 derived from tem-2 beta-lactamase produced by proteus mirabilis strains.
Journal of Antimicrobial Chemotherapy., pages 183-91, 1996 Aug.
Abstract.
[60]  Chanal-Claris C. Sirot D. Bret L. Chatron P. Labia R. Sirot J.
Novel extended-spectrum tem-type beta-lactamase from an escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
Antimicrobial Agents and Chemotherapy., pages 715-6, 1997 Mar.
[61]  Lemozy J. Sirot D. Chanal C. Huc C. Labia R. Dabernat H. Sirot J.
First characterization of inhibitor-resistant tem (irt) beta-lactamases in klebsiella pneumoniae strains.
Antimicrobial Agents and Chemotherapy., pages 2580-2, 1995 Nov.
[62]  Sirot D. Recule C. Chaibi EB. Bret L. Croize J. Chanal-Claris C. Labia R. Sirot J.
A complex mutant of tem-1 beta-lactamase with mutations encountered in both irt-4 and extended-spectrum tem-15, produced by an escherichia coli clinical isolate.
Antimicrobial Agents and Chemotherapy., pages 1322-5, 1997 Jun.
[63]  Bellido F. Veuthey C. Blaser J. Bauernfeind A. Pechere JC.
Novel resistance to imipenem associated with an altered pbp-4 in a pseudomonas aeruginosa clinical isolate.
Journal of Antimicrobial Chemotherapy., pages 57-68, 1990 Jan.
[64]  Fosberry AP. Payne DJ. Lawlor EJ. Hodgson JE.
Cloning and sequence analysis of blabil-1, a plasmid-mediated class c beta-lactamase gene in escherichia coli bs.
Antimicrobial Agents and Chemotherapy., pages 1182-5, 1994 May.
[65]  Kelly MD. Mortensen JE.
A low-copy number plasmid mediating beta-lactamase production by xanthomonas maltophilia.
Advances in Experimental Medicine and Biology., 1995.
[Review] [18 refs].
[66]  Urban C. Rahal JJ.
Klebsiella and extended spectrum beta-lactamases.
International Journal of Antimicrobial Agents., pages 37-43, 1997 Feb.
[67]  Bauernfeind A. Stemplinger I. Jungwirth R. Ernst S. Casellas JM.
Sequences of beta-lactamase genes encoding ctx-m-1 (men-1) and ctx-m-2 and relationship of their amino acid sequences with those of other beta-lactamases.
Antimicrobial Agents and Chemotherapy., pages 509-13, 1996 Feb.
[68]  Bauernfeind A. Stemplinger I. Jungwirth R. Mangold P. Amann S. Akalin E. Ang O. Bal C. Casellas JM.
Characterization of beta-lactamase gene blaper-2, which encodes an extended-spectrum class a beta-lactamase (also in e.coli).
Antimicrobial Agents and Chemotherapy., pages 616-20, 1996 Mar.
[69]  Perilli M. Franceschini N. Segatore B. Amicosante G. Oratore A. Duez C. Joris B. Frere JM.
Cloning and nucleotide sequencing of the gene encoding the beta-lactamase from citrobacter diversus.
FEMS Microbiology Letters., pages 79-84, 1991 Sep 15.
[70]  Lodge JM. Minchin SD. Piddock LJ. Busby JW.
Cloning, sequencing and analysis of the structural gene and regulatory region of the pseudomonas aeruginosa chromosomal ampc beta- lactamase.
Biochemical Journal., pages 627-31, 1990 Dec 15.
[71]  Bradford PA. Cherubin CE. Idemyor V. Rasmussen BA. Bush K.
Multiply resistant klebsiella pneumoniae strains from two chicago hospitals: identification of the extended-spectrum tem-12 and tem-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
Antimicrobial Agents and Chemotherapy., pages 761-6, 1994 Apr.
[72]  Bradford PA. Jacobus NV. Bhachech N. Bush K.
Tem-28 from an escherichia coli clinical isolate is a member of the his-164 family of tem-1 extended-spectrum beta-lactamases.
Antimicrobial Agents and Chemotherapy., pages 260-2, 1996 Jan.
[73]  Bradford PA. Urban C. Jaiswal A. Mariano N. Rasmussen BA. Projan SJ. Rahal JJ. Bush K.
Shv-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in escherichia coli isolates from hospitalized nursing home patients.
Antimicrobial Agents and Chemotherapy., pages 899-905, 1995 Apr.
published erratum appears in Antimicrob Agents Chemother 1995 Jul;39(7) 1646.
[74]  Bradford PA. Urban C. Mariano N. Projan SJ. Rahal JJ. Bush K.
Imipenem resistance in klebsiella pneumoniae is associated with the combination of act-1, a plasmid-mediated ampc beta-lactamase, and the loss of an outer membrane protein.
Antimicrobial Agents and Chemotherapy., pages 563-9, 1997 Mar.
[75]  Li XZ. Zhang L. Srikumar R. Poole K.
Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 399-403, 1998 Feb.
[76]  Marumo K. Takeda A. Nakamura Y. Nakaya K.
Purification and characterization of metallo-beta-lactamase from serratia marcescens.
Microbiology and Immunology., pages 27-33, 1995.
[77]  Pornull KJ. Rodrigo G. Dornbusch K.
Production of a plasmid mediated ampc-like beta-lactamase by a klebsiella pneumoniae septicaemia isolate.
Journal of Antimicrobial Chemotherapy., pages 943-54, 1994 Dec.
[78]  Rasmussen BA. Bradford PA. Quinn JP. Wiener J. Weinstein RA. Bush K.
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of tem-10 beta-lactamases encoded by different nucleotide sequences.
Antimicrobial Agents and Chemotherapy., pages 1989-92, 1993 Sep.
[79]  Rasmussen BA. Keeney D. Yang Y. Bush K.
Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from aeromonas sobria aer 14m in escherichia coli: requirement for an e. coli chromosomal mutation for efficient expression of the class d enzyme.
Antimicrobial Agents and Chemotherapy., pages 2078-85, 1994 Sep.
[80]  Urban C. Meyer KS. Mariano N. Rahal JJ. Flamm R. Rasmussen BA. Bush K.
Identification of tem-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy., pages 392-5, 1994 Feb.
[81]  Yang Y. Bush K.
Biochemical characterization of the carbapenem-hydrolyzing beta-lactamase asbm1 from aeromonas sobria aer 14m: a member of a novel subgroup of metallo-beta-lactamases.
FEMS Microbiology Letters., pages 193-200, 1996 Apr 1.
[82]  Lee EH. Nicolas MH. Kitzis MD. Pialoux G. Collatz E. Gutmann L.
Association of two resistance mechanisms in a clinical isolate of enterobacter cloacae with high-level resistance to imipenem.
Antimicrobial Agents and Chemotherapy., pages 1093-8, 1991 Jun.
[83]  Liu Y. Mee BJ. Mulgrave L.
Identification of clinical isolates of indole-positive klebsiella spp., including klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.
Journal of Clinical Microbiology., pages 2365-9, 1997 Sep.
[84]  Lodge J. Busby S. Piddock L.
Investigation of the pseudomonas aeruginosa ampr gene and its role at the chromosomal ampc beta-lactamase promoter.
FEMS Microbiology Letters., pages 315-20, 1993.
[85]  Mainardi JL. Mugnier P. Coutrot A. Buu-Hoi A. Collatz E. Gutmann L.
Carbapenem resistance in a clinical isolate of citrobacter freundii.
Antimicrobial Agents and Chemotherapy., pages 2352-4, 1997 Nov.
[86]  Zhou XY. Kitzis MD. Gutmann L.
Role of cephalosporinase in carbapenem resistance of clinical isolates of pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 1387-9, 1993 Jun.
[87]  Haeggman S. Lofdahl S. Burman LG.
An allelic variant of the chromosomal gene for class a beta-lactamase k2, specific for klebsiella pneumoniae, is the ancestor of shv-1.
Antimicrobial Agents and Chemotherapy, pages 2705-2709, 1997 Dec.
[88]  Prinarakis EE. Miriagou V. Tzelepi E. Gazouli M. Tzouvelekis LS.
Emergence of an inhibitor-resistant beta-lactamase (shv-10) derived from an shv-5 variant.
Antimicrobial Agents and Chemotherapy., pages 838-40, 1997 Apr.
[89]  Prinarakis EE. Tzelepi E. Gazouli M. Mentis AF. Tzouvelekis LS.
Characterization of a novel shv beta-lactamase variant that resembles the shv-5 enzyme.
FEMS Microbiology Letters., pages 229-34, 1996 Jun 1.
[90]  Arakawa Y. Murakami M. Suzuki K. Ito H. Wacharotayankun R. Ohsuka S. Kato N. Ohta M.
A novel integron-like element carrying the metallo-beta-lactamase gene blaimp.
Antimicrobial Agents and Chemotherapy., pages 1612-5, 1995 Jul.
[91]  Cheng Y. Chen M.
Nucleotide sequence analysis of shv-2 beta-lactamase gene in enterobacter gergoviae.
Wei Sheng Wu Hsueh Pao - Acta Microbiologica Sinica., pages 226-30, 1994 Jun.
Chinese.
[92]  Cheng Y. Li Y. Chen M.
A plasmid-mediated shv type extended-spectrum beta-lactamase in beijing isolate of enterobacter gergoviae.
Wei Sheng Wu Hsueh Pao - Acta Microbiologica Sinica., pages 106-12, 1994 Apr.
[Chinese].
[93]  Ito H. Arakawa Y. Ohsuka S. Wacharotayankun R. Kato N. Ohta M.
Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaimp among clinically isolated strains of serratia marcescens.
Antimicrobial Agents and Chemotherapy., pages 824-9, 1995 Apr.
[94]  Kimura K. Arakawa Y. Ohsuka S. Ito H. Suzuki K. Kurokawa H. Kato N. Ohta M.
Molecular aspects of high-level resistance to sulbactam-cefoperazone in klebsiella oxytoca clinical isolates.
Antimicrobial Agents and Chemotherapy., pages 1988-94, 1996 Sep.
[95]  Kunugita C. Higashitani F. Hyodo A. Unemi N. Inoue M.
Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from serratia marcescens.
Journal of Antibiotics., pages 1453-9, 1995 Dec.
[96]  Sanchez L. Ruiz N. Leranoz S. Vinas M. Puig M.
The role of outer membrane in serratia marcescens intrinsic resistance to antibiotics. [review] [24 refs].
Microbiologia., pages 315-20, 1997 Sep.
[97]  Senda K. Arakawa Y. Ichiyama S. Nakashima K. Ito H. Ohsuka S. Shimokata K. Kato N. Ohta M.
Pcr detection of metallo-beta-lactamase gene (blaimp) in gram-negative rods resistant to broad-spectrum beta-lactams.
Journal of Clinical Microbiology., pages 2909-13, 1996 Dec.
[98]  Senda K. Arakawa Y. Nakashima K. Ito H. Ichiyama S. Shimokata K. Kato N. Ohta M.
Multifocal outbreaks of metallo-beta-lactamase-producing pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.
Antimicrobial Agents and Chemotherapy., pages 349-53, 1996 Feb.
[99]  Vahaboglu H. Ozturk R. Aygun G. Coskunkan F. Yaman A. Kaygusuz A. Leblebicioglu H. Balik I. Aydin K. Otkun M.
Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.
unknow, 1997.
[100]  Vahaboglu H. Ozturk R. Aygun G. Coskunkan F. Yaman A. Kaygusuz A. Leblebicioglu H. Balik I. Aydin K. Otkun M.
Widespread detection of per-1-type extended-spectrum beta- lactamases among nosocomial acinetobacter and pseudomonas aeruginosa isolates in turkey: a nationwide multicenter study.
Antimicrobial Agents and Chemotherapy., pages 2265-9, 1997 Oct.
[101]  Valladares MH. Felici A. Weber G. Adolph HW. Zeppezauer M. Rossolini GM. Amicosante G. Frere JM. Galleni M.
Zn(ii) dependence of the aeromonas hydrophila ae036 metallo-beta-lactamaseactivity and stability.
Biochemistry., pages 11534-11541, 1997 Sep 23.
[102]  Venezia RA. Scarano FJ. Preston KE. Steele LM. Root TP. Limberger R. Archinal W. Kacica MA.
Molecular epidemiology of an shv-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.
Clinical Infectious Diseases., pages 915-23, 1995 Oct.
[103]  Hashizume T. Sanada M. Nakagawa S. Tanaka N.
Alteration in expression of serratia marcescens porins associated with decreased outer membrane permeability.
Journal of Antimicrobial Chemotherapy., pages 21-8, 1993 Jan.
[104]  Osano E. Arakawa Y. Wacharotayankun R. Ohta M. Horii T. Ito H. Yoshimura F. Kato N.
Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of serratia marcescens that shows imipenem resistance.
Antimicrobial Agents and Chemotherapy., pages 71-8, 1994 Jan.
[105]  Tzouvelekis LS. Tzelepi E. Prinarakis E. Gazouli M. Katrahoura A. Giakkoupi P. Paniara O. Legakis NJ.
Sporadic emergence of klebsiella pneumoniae strains resistant to cefepime and cefpirome in greek hospitals.
Journal of Clinical Microbiology., pages 266-268, 1998 Jan.
[106]  Carfi A. Duee E. Paulsoto R. Galleni M. Frere JM. Dideberg O.
X-ray structure of the zn-ii beta-lactamase from bacteroides fragilis in an orthorhombic crystal form.
Acta Crystallographica Section D-Biological Crystallography., pages 47-57, 1998 Jan.
[107]  Concha NO. Rasmussen BA. Bush K. Herzberg O.
Crystal structure of the wide-spectrum binuclear zinc beta- lactamase from bacteroides fragilis.
Structure., pages 823-36, 1996 Jul 15.
[108]  Concha NO. Rasmussen BA. Bush K. Herzberg O.
Crystal structures of the cadmium- and mercury-substituted metallo-beta-lactamase from bacteroides fragilis.
Protein Science., pages 2671-2676, 1997 Dec.
[109]  Naas T. Livermore DM. Nordmann P.
Characterization of an lysr family protein, smer from serratia marcescens s6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase sme-1, and comparison of this regulator with other beta-lactamase regulators.
Antimicrobial Agents and Chemotherapy., pages 629-37, 1995 Mar.
[110]  Naas T. Vandel L. Sougakoff W. Livermore DM. Nordmann P.
Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class a beta-lactamase, sme-1, from serratia marcescens s6.
Antimicrobial Agents and Chemotherapy., pages 1262-70, 1994 Jun.
[111]  Philippon LN. Naas T. Bouthors AT. Barakett V. Nordmann P.
Oxa-18, a class d clavulanic acid-inhibited extended-spectrum beta-lactamase from pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 2188-95, 1997 Oct.
[112]  Poyart C. Mugnier P. Quesne G. Berche P. Trieucuot P.
A novel extended-spectrum tem-type beta-lactamase (tem-52) associated with decreased susceptibility to moxalactam in klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy., pages 108-113, 1998 Jan.
[113]  Rossolini GM. Zanchi A. Chiesurin A. Amicosante G. Satta G. Guglielmetti P.
Distribution of cpha or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus aeromonas.
Antimicrobial Agents and Chemotherapy., pages 346-9, 1995 Feb.
[114]  Fournier B. Roy PH.
Variability of chromosomally encoded beta-lactamases from klebsiella oxytoca.
Antimicrobial Agents and Chemotherapy., pages 1641-8, 1997 Aug.
[115]  Hibbert-Rogers LC. Heritage J. Todd N. Hawkey PM.
Convergent evolution of tem-26, a beta-lactamase with extended-spectrum activity.
Journal of Antimicrobial Chemotherapy., pages 707-20, 1994 Apr.
[116]  Hibbert-Rogers LC. Heritage J. Todd N. Hawkey PM.
Convergent evolution of tem-26, a beta-lactamase with extended-spectrum activity.
Journal of Antimicrobial Chemotherapy., pages 707-20, 1994 Apr.
[117]  Jones ME. Bennett PM.
Inducible expression of the chromosomal cdia from citrobacter diversus nf85, encoding an ambler class a beta-lactamase, is under similar genetic control to the chromosomal ampc, encoding an ambler class c enzyme, from citrobacter freundii os60.
Microbial Drug Resistance., pages 285-91, 1995 Winter.
[118]  Oliva B. Segatore B. Amicosante G. Franceschini N. Oratore A. Bennett PM.
Broad spectrum beta-lactamases of citrobacter diversus.
Journal of Antimicrobial Chemotherapy., pages 335-41, 1990 Mar.
[119]  Walsh TR. Gamblin S. Emery DC. MacGowan AP. Bennett PM.
Enzyme kinetics and biochemical analysis of imis, the metallo-beta-lactamase from aeromonas sobria 163a.
Journal of Antimicrobial Chemotherapy., pages 423-31, 1996 Mar.
[120]  Walsh TR. Hall L. Assinder SJ. Nichols WW. Cartwright SJ. MacGowan AP. Bennett PM.
Sequence analysis of the l1 metallo-beta-lactamase from xanthomonas maltophilia.
Biochimica et Biophysica Acta., pages 199-201, 1994 Jun 21.
[121]  Walsh TR. MacGowan AP. Bennett PM.
Sequence analysis and enzyme kinetics of the l2 serine beta-lactamase from stenotrophomonas maltophilia.
Antimicrobial Agents and Chemotherapy., pages 1460-4, 1997 Jul.
[122]  Walsh TR. Neville WA. Haran MH. Tolson D. Payne DJ. Bateson JH. Macgowan AP. Bennett PM.
Nucleotide and amino acid sequences of the metallo-beta-lactamase, imis, from aeromonas veronii bv. sobria.
Antimicrobial Agents and Chemotherapy., pages 436-439, 1998 Feb.
[123]  Walsh TR. Payne DJ. MacGowan AP. Bennett PM.
A clinical isolate of aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity.
Journal of Antimicrobial Chemotherapy., pages 271-9, 1995 Feb.
[124]  Amicosante G. Frere JM. Franceschini N. Oratore A. Strom R.
Some molecular properties of citrobacter diversus beta-lactamases.
Journal of Chemotherapy., pages 83-5, 1991 Apr.
[125]  Bermudes H. Jude F. Arpin C. Quentin C. Morand A. Labia R.
Characterization of an inhibitor-resistant tem (irt) beta-lactamase in a novel strain of klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy., page 222, 1997 Jan.
[letter].
[126]  Chaves J. Coira A. Segura C. Reig R.
Identification and location of the shv-1 gene in klebsiella pneumoniae strains.
Journal of Chemotherapy., pages 49-51, 1995 Nov.
[127]  Edwards R.
Resistance to beta-lactam antibiotics in bacteroides spp.
Journal of Medical Microbiology, pages 979-986, 1997 Dec.
[Review].
[128]  Farzaneh S. Peduzzi J. Sofer L. Reynaud A. Barthelemy M. Labia R.
Characterization and amino acid sequence of the oxy-2 group beta-lactamase of pi 5.7 isolated from aztreonam-resistant klebsiella oxytoca strain hb60.
Journal of Antimicrobial Chemotherapy., pages 789-795, 1997 Dec.
[129]  Hornstein M. Sautjeau-Rostoker C. Peduzzi J. Vessieres A. Hong LT. Barthelemy M. Scavizzi M. Labia R.
Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in acinetobacter baumannii.
FEMS Microbiology Letters., 153(2):333-9, 1997 Aug 15.
[130]  Nordmann P. Ronco E. Naas T. Duport C. Michel-Briand Y. Labia R.
Characterization of a novel extended-spectrum beta-lactamase from pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 962-9, 1993 May.
[131]  Soilleux MJ. Morand AM. Arlet GJ. Scavizzi MR. Labia R.
Survey of klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of tem-3 and first identification of tem-26 in france.
Antimicrobial Agents and Chemotherapy., pages 1027-9, 1996 Apr.
[132]  Bartowsky E. Normark S.
Interactions of wild-type and mutant ampr of citrobacter freundii with target dna.
Molecular Microbiology., pages 555-65, 1993 Nov.
[133]  Iyobe S. Tsunoda M. Mitsuhashi S.
Cloning and expression in enterobacteriaceae of the extended- spectrum beta-lactamase gene from a pseudomonas aeruginosa plasmid.
FEMS Microbiology Letters., pages 175-80, 1994 Aug 15.
[134]  Jacobs C. Frere JM. Normark S.
Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria.
Cell., pages 823-832, 1997 Mar 21.
[135]  Kopp U. Wiedemann B. Lindquist S. Normark S.
Sequences of wild-type and mutant ampd genes of citrobacter freundii and enterobacter cloacae.
Antimicrobial Agent and Chemotherapy., pages 224-8, 1993 Feb.
[136]  Lindquist S. Weston-Hafer K. Schmidt H. Pul C. Korfmann G. Erickson J. Sanders C. Martin HH. Normark S.
Ampg, a signal transducer in chromosomal beta-lactamase induction.
Molecular Microbiology., pages 703-15, 1993 Aug.
[137]  Matsumura N. Minami S. Mitsuhashi S.
Sequences of homologous beta-lactamases from clinical isolates of serratia marcescens with different substrate specificities.
Antimicrobial Agents and Chemotherapy., pages 176-179, 1998 Jan.
[138]  Matsumura N. Mitsuhashi S.
A beta-lactamase from serratia marcescens hydrolyzing the 2-carboxypenam t-5575.
Antimicrobial Agents and Chemotherapy., pages 2132-4, 1995 Sep.
[139]  Minami S. Akama M. Araki H. Watanabe Y. Narita H. Iyobe S. Mitsuhashi S.
Imipenem and cephem resistant pseudomonas aeruginosa carrying plasmids coding for class b beta-lactamase.
Journal of Antimicrobial Chemotherapy., pages 433-44, 1996 Mar.
[140]  Watanabe M. Iyobe S. Inoue M. Mitsuhashi S.
Transferable imipenem resistance in pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy., pages 147-51, 1991 Jan.
[141]  s Horii T. Arakawa Y. Ohta M. Sugiyama T. Wacharotayankun R. Ito H. Kato N.
Characterization of a plasmid-borne and constitutively expressed blamox-1 gene encoding ampc-type beta-lactamase.
Gene., pages 93-8, 1994 Feb 11.
[142]  Paton R. Miles RS. Amyes SG.
Biochemical properties of inducible beta-lactamases produced from xanthomonas maltophilia.
Antimicrobial Agents and Chemotherapy., pages 2143-9, 1994 Sep.
[143]  Crowder MW. Wang Z. Franklin SL. Zovinka EP. Benkovic SJ.
Characterization of the metal-binding sites of the beta- lactamase from bacteroides fragilis.
Biochemistry., pages 12126-32, 1996 Sep 17.
[144]  Roh IK. Kim IJ. Chung JH. Byun SM.
Affinity purification and binding characteristics of citrobacter freundii ampr, the transcriptional regulator of the ampc beta-lactamase gene.
Biotechnology and Applied Biochemistry., pages 149-54, 1996 Apr.
[145]  Gotoh N. Nunomura K. Nishino T.
Resistance of pseudomonas aeruginosa to cefsulodin: modification of penicillin-binding protein 3 and mapping of its chromosomal gene.
Journal of Antimicrobial Chemotherapy., pages 513-23, 1990 Apr.
[146]  Ito Y. Hirano T.
Carbenicillin-hydrolysing penicillinase mediated by a plasmid of proteus mirabilis and its relationship to the pse-type enzymes of pseudomonas aeruginosa.
Journal of Applied Microbiology., pages 175-180, 1997 Aug.
[147]  Nomura K. Yoshida T.
Nucleotide sequence of the serratia marcescens sr50 chromosomal ampc beta-lactamase gene.
FEMS Microbiology Letters., pages 295-9, 1990 Aug.
[148]  Nordmann P. Naas T.
Sequence analysis of per-1 extended-spectrum beta-lactamase from pseudomonas aeruginosa and comparison with class a beta-lactamases.
Antimicrobial Agents and Chemotherapy., pages 104-14, 1994 Jan.
[149]  Satake S. Yoneyama H. Nakae T.
Role of ompd2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of pseudomonas aeruginosa.
Journal of Antimicrobial Chemotherapy., pages 199-207, 1991 Aug.
[150]  Sougakoff W. Jarlier V. Delettre J. Colloc’h N. L’Hermite G. Nordmann P. Naas T.
Purification, crystallization, and preliminary x-ray diffraction analysis of the carbapenem-hydrolyzing class a beta-lactamase sme-1 from serratia marcescens.
Journal of Structural Biology., pages 313-6, 1996 Mar-Apr.
[151]  Tsukamoto K. Ohno R. Nukaga M. Sawai T.
The effect of amino acid substitution at position 219 of citrobacter freundii cephalosporinase on extension of its substrate spectrum.
European Journal of Biochemistry., pages 1123-7, 1992 Aug 1.
[152]  Palzkill T. Thomson KS. Sanders CC. Moland ES. Huang W. Milligan TW.
New variant of tem-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis.
Antimicrobial Agents and Chemotherapy., pages 1199-200, 1995 May.
Abstract.
[153]  Franceschini N. Amicosante G. Perilli M. Maccarrone M. Oratore A. van Beeumen J. Frere JM.
Proteolytic interconversion and n-terminal sequences of the citrobacter diversus major beta-lactamases [published erratum appears in biochem j.
Biochemical Journal, pages 629-33, 1991 May 1.
[154]  Stoorvogel J. van Gestel MH. Ketelaar-van Gaalen PA. Mouton RP. van de Klundert JA.
Variation in induction of chromosomal beta-lactamase expression in strains of enterobacter cloacae.
Chemotherapy., pages 175-85, 1991.
[155]  Jacobs C. Joris B. Jamin M. Klarsov K. Van Beeumen J. Mengin-Lecreulx D. van Heijenoort J. Park JT. Normark S. Frere JM.
Ampd, essential for both beta-lactamase regulation and cell wall recycling, is a novel cytosolic n-acetylmuramyl-l-alanine amidase.
Molecular Microbiology., pages 553-9, 1995 Feb.
[156]  Bouthors AT. Dagoneaublanchard N. Naas T. Nordmann P. Jarlier V. Sougakoff W.
Role of residues 104, 164, 166, 238 and 240 in the substrate profile of per-1 beta-lactamase hydrolysing third-generation cephalosporins.
Biochemical Journal., pages 1443-1449, 1998 Mar 15.
[157]  Gehrlein M. Leying H. Cullmann W. Wendt S. Opferkuch W.
Imipenem resistance in acinetobacter baumanii is due to altered penicillin-binding proteins.
Chemotherapy., 37(6):405-12, 1991.
[158]  Bauernfeind A. Stemplinger I. Jungwirth R. Wilhelm R. Chong Y.
Comparative characterization of the cephamycinase blacmy-1 gene and its relationship with other beta-lactamase genes.
Antimicrobial Agents and Chemotherapy., pages 1926-30, 1996 Aug.
[159]  Goto M. Takahashi T. Yamashita F. Koreeda A. Mori H. Ohta M. Arakawa Y.
Inhibition of the metallo-beta-lactamase produced from serratia marcescens by thiol compounds.
Biological and Pharmaceutical Bulletin., pages 1136-40, 1997 Nov.
     Page précédentePage suivanteSommaireVersion imprimable